Kalivir Immunotherapeutics, Inc. (United States)
main - KaliVir Immunotherapeutics
multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. LEARN MORE NEWS AND EVENTSAugust 19, 2026 - KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing READ MORE November 19, 2025 - KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate
Company details
- Address
- United States
- Website
- kalivir.com
Reviews
No reviews yet.
All reviews of Kalivir Immunotherapeutics, Inc. (United States) · Write a review
Domain and WHOIS record
- Domain
- kalivir.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 19 Jun 2019
- Expires
- 19 Jun 2029
- Record updated
- 28 Oct 2022
- Name servers
- ns53.domaincontrol.com, ns54.domaincontrol.com
- DNSSEC
- Not signed